Replies to post #21952 on BioRestorative Therapies Inc (BRTX)

[SPORTYNORTY]

BRTXQ--That is the response.

Obviously, playing the result, one can pontificate that it was the right decision NOT to finance or partner with BRTX back in 2018. The company's technology was in the embryonic stages and not enough data had been gathered to make an informed investment decision. The eventual outcome, bankruptcy. So all of those companies that passed on BRTX at that time, made the right decision.

Now, two years later, with the debt about to be eviscerated, and their technology progressing along more expeditiously into the later phases, they are a MUCH better business wager.

Seemingly, I feel that the question posed, in light of the creation of the account, that individual already knew that.

Nothing more related to this needs to be stated or affirmed, COMMON SENSE.

[hendigitty]

I agree. Its not how you start but how you finish. Brtxq with the help of Auctus will learn from their mistakes. The patents are not only super valuable but millions of people that experience degenerative discs in the vertebral column will have an alternative to back surgery. Im super excited to know that Biorestorative ia a top key player in the game and the companes that surround them speaks volumes. BRTX$$$$$

Top Key Players:

Samumed LLC
DiscGenics Inc
U.S. Stem Cell Inc
BioRestorative Therapies Inc
Biopharm GmbH
AnGes Inc
Bone Therapeutics SA
Kolon TissueGene Inc
Mesoblast
Yuhan Corp
Osiris Therapeutics Inc